Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Nephrology/Urology
Disease Category: Prostate Cancer
Trial Information
A Randomized, Double Blind, Placebo Controlled Trial of Immunotherapy with Autologous Antigen-Loaded Dendritic Cells For Asymptomatic Metastatic Hormone Refractory Prostate Cancer.
You may qualify to participate in this Phase 3 clinical trial if
you have all of the following:
- Cancer that has spread outside the prostate (metastatic)
- Cancer that has progressed while on hormone therapy
- Gleason Score of 7 or lower
- No cancer related pain
Maureen Lampo, Study Coordinator
Staten Island Urological Research, P.C.
1800 Clove Road
Staten Island, NY 10304
Phone: 718-720-6040
Fax: 718-720-6523
EMail: mlampo@urocancer.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
